Aptus Pharma Limited - trading in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2010PLC061957 Incorporated 12 August 2010 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - BSE: 544529 Public Limited Company trading MSME · Small
Market Cap
₹820 Cr
APPL · BSE
Share Price
₹487.45
+2.00% today
Revenue
₹46.57 Cr
FY 2025-26 · +89.6% YoY
EBITDA
₹7.43 Cr
Margin 15.9%
Net Profit
₹4.60 Cr
FY 2025-26 · +48.9% YoY
ROE
30.5%
ROCE 29.6%
Debt / Equity
0.58
Interest cover 11.4x
Authorised capital
₹25 Cr
Registered with MCA

About Aptus Pharma Limited

Data last updated:

Aptus Pharma Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 12 August 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PLC061957. Its GSTIN is 24AAICA7890D1ZM (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 544529.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.15 Cr. It is led by directors including Tejash Maheshchandra Hathi (Managing Director) and Sejal Harit Palan.

Its last annual general meeting (AGM) was held on 14 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Harikrupa Logistic Park, Ahmedabad, Gujarat.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹46.57 Cr, a growth of 89.6% compared to the previous year. For the same year it recorded a net profit of ₹4.6 Cr (net margin 9.9%) and EBITDA of ₹7.43 Cr (EBITDA margin 16%). The net worth stands at ₹23.35 Cr (up 235% YoY). Total assets are valued at ₹30.89 Cr (up 75.8% YoY).

The company has about 28 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Aptus Pharmaceuticals. As per MCA filings, the company has open charges of ₹12.63 Cr and satisfied charges of ₹3 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 1 smaller; the largest is Us Amino Private Limited with revenue of ₹24.84 Cr.

Aptus Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-20-0028039). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aptus-pharma.com.

Company details

CIN U24230GJ2010PLC061957
Registration Number 061957
Incorporation Date 12 August 2010
ROC Ahmedabad
Listing Status Listed - Listed on BSE (544529)
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-20-0028039

CIN history

Aptus Pharma has one previous CIN (Corporate Identification Number): U24230GJ2010PTC061957. The current CIN is U24230GJ2010PLC061957, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230GJ2010PLC061957Current
U24230GJ2010PTC061957Previous

Recognitions & Rankings of Aptus Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-20-0028039

Contact details

Aptus Pharma Limited's registered office is in Ahmedabad, Gujarat.

  • Registered Address
    Ashutosh Buildcon Opp. Slok 2, Nr. Harikrupa Logistic Park Aslali, Ahmedabad, Gujarat, India – 382427
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
Aptus Pharma Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aptus Pharma operates one associated brand: Aptus Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Limited information availableaptuspharma.com

Business activity

The main business activity of Aptus Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Aptus Pharma Limited, buy the company report.

Financials of Aptus Pharma Limited

FY 2025-26 filings available

Aptus Pharma Limited reported revenue of ₹46.57 Cr (up 89.6% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹46.57 Cr
+89.6% YoY
EBITDA
₹7.43 Cr
+53.5% YoY
Profit After Tax
₹4.60 Cr
+48.9% YoY
Net Worth
₹23.35 Cr
+235.0% YoY
Total Assets
₹30.89 Cr
+75.8% YoY
Total Debt
₹7.18 Cr
-30.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue46.5724.5617.8613.90
Revenue growth+89.6%+37.5%+28.5%-
EBITDA7.434.841.550.62
EBITDA margin+16.0%+19.7%+8.7%+4.5%
Profit before tax6.354.181.130.30
Net profit4.603.090.810.20
Net profit margin+9.9%+12.6%+4.5%+1.4%
EPS (₹)6.736.2026.606.48
Balance sheet
Total assets30.8917.577.243.29
Net worth23.356.971.770.97
Total debt7.1810.365.312.22
Cash & bank1.035.210.910.54
Net working capital22.5915.395.532.72
Cash flow
Cash from operations(5.60)(1.84)(2.17)(0.18)
Cash from investing(6.37)(0.54)(0.30)(0.35)
Cash from financing7.796.682.860.81

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Nov 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Revenue46.5724.5617.8613.90
Revenue growth+89.6%+37.5%+28.5%-
Other income0.130.080.030.00
Total expenses39.1419.7216.3113.28
Employee cost5.213.572.311.57
EBITDA7.434.841.550.62
EBITDA margin+16.0%+19.7%+8.7%+4.5%
Depreciation0.410.270.210.18
Interest0.800.470.240.14
Profit before tax6.354.181.130.30
Tax1.751.090.320.10
Net profit4.603.090.810.20
Net profit margin+9.9%+12.6%+4.5%+1.4%
EPS (₹)6.736.2026.606.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital6.865.000.300.30
Reserves & surplus16.491.971.470.67
Shareholders' funds (net worth)23.356.971.770.97
Secured loans4.665.491.580.33
Unsecured loans2.524.873.731.89
Total debt7.1810.365.312.22
Total liabilities30.8917.577.243.29
Assets
Gross block4.041.861.240.91
Net block2.760.990.640.52
Capital work in progress0.000.000.000.00
Investments0.000.000.000.00
Inventories13.577.063.432.30
Sundry debtors18.765.643.352.40
Cash & bank balances1.035.210.910.54
Loans & advances1.881.830.620.41
Total current assets35.2419.748.315.65
Total current liabilities12.654.352.782.93
Net working capital22.5915.395.532.72
Total assets30.8917.577.243.29
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Opening cash5.210.910.540.26
Net cash from operating activities(5.60)(1.84)(2.17)(0.18)
Net cash from investing activities(6.37)(0.54)(0.30)(0.35)
Net cash from financing activities7.796.682.860.81
Net change in cash(4.19)4.300.380.28
Closing cash1.035.210.910.54
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth+89.6%+37.5%+28.5%-
EBITDA growth+53.5%+212.3%+150.0%-
PBT growth+51.9%+269.9%+276.7%+9997.0%
Net income growth+48.9%+281.5%+305.0%-
Revenue CAGR (3Y)+49.6%---
EBITDA CAGR (3Y)+128.8%---
Profitability & leverage
Net income margin+9.9%+12.6%+4.5%+1.4%
Return on capital employed+29.6%+37.6%+25.8%+13.1%
Return on net worth+30.5%+70.9%+58.4%+19.6%
Debt / equity0.581.792.742.28
Long-term debt / equity0.100.752.182.07
Interest cover11.4010.2817.9131.82
Efficiency & per share
Fixed asset turnover15.7915.8516.6115.27
Inventory turnover4.514.686.236.04
Debtors turnover3.825.466.215.79
EPS (₹)6.736.2026.606.48
Dividend per share (₹)0.000.000.000.00
Book value per share (₹)34.0313.9358.8832.28

To see the full year-wise statements and ratios of Aptus Pharma Limited, buy the company report.

Board of directors of Aptus Pharma Limited

Aptus Pharma has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tejash Maheshchandra HathiManaging Director12 Aug 201016 Years 3 MonthsCurrent
Sejal Harit PalanDirector06 Feb 20251 Years 9 MonthsCurrent
Vikas Rambhai JobanputraDirector06 Feb 20251 Years 9 MonthsCurrent
Jyotiben Hasmukhbhai ChandaranaDirector20 May 20242 Years 6 MonthsCurrent
Chetan Shantilal LalsetaDirector17 Jan 20242 Years 10 MonthsCurrent
Riddhish Natwarlal TannaDirector17 Jan 20242 Years 10 MonthsCurrent

Peer comparison

Aptus Pharma Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aptus Pharma Limitedthis company₹46.57 Cr (FY 2026)₹4.6 Cr9.9%89.6%Ahmedabad, Gujarat, India
Us Amino Private Limited₹24.84 Cr (FY 2024)-3.0%Mavli, Rajasthan, India
Zenacts Pharma Private Limited₹24.74 Cr (FY 2024)-10.0%Chandigarh, India
Pvpharma Healthcare Private Limited₹24.71 Cr (FY 2025)8.0%Ahmedabad, Gujarat, India
Saviour Wellness Private Limited₹24.62 Cr (FY 2025)15.0%New Delhi, Delhi, India

To see the full peer comparison of Aptus Pharma Limited, buy the company report.

Charges & borrowings

Open charges
₹12.63 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Others₹12.63 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jun 2026101336736Others₹88 LakhOpen
10 Apr 2026101282364Others₹1.75 CrOpen
27 Feb 2024100880005Others₹10 CrOpen
28 Apr 2023100722274Hdfc Bank Limited₹2 CrSatisfied
15 Jul 2020100361810Others₹5.85 LakhSatisfied

To see the full charge records of Aptus Pharma Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Aptus Pharma Limited has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025.

Total deals
11
Market trades
10
IPO
1

Deals on record (5 of 11)

WhenDealAmountParties
Dec 2025Market trade₹61.4 LakhSeller: Zeal Global Opportunities Fund
Dec 2025Market trade₹1.54 CrSeller: 31 Degrees North Fund I
Nov 2025Market trade₹60.6 LakhSeller: Zeal Global Opportunities Fund
Oct 2025Market trade₹30.8 LakhSeller: Pure Broking Private Limited
Sep 2025Market trade₹3.11 CrBuyer: Pure Broking Private Limited , 2 individuals

To see the full deal history of Aptus Pharma Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aptus Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Aptus Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAICA7890D1ZMGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Aptus Pharma Limited, buy the company report.

Recent activity

Aptus Pharma Limited has 16 board changes on record since 2010: 6 appointments and 10 cessations. The latest: Chetan Shantilal Lalseta ceased to be Director on 09 Nov 2025.

AGM
Aptus Pharma Limited last Annual general meeting of members was held on 14 Sep 2026 as per latest MCA records.
Charges
A charge with Others of Rs. 0.88 Cr registered on 27 Jun 2026 with Charge ID 101336736 was modified on 27 Jul 2026.
Charges
A charge with Others amounted to Rs. 0.88 Cr with Charge ID 101336736 was registered on 27 Jun 2026.
Charges
A charge with Others of Rs. 10.00 Cr registered on 27 Feb 2024 with Charge ID 100880005 was modified on 16 Apr 2026.
Charges
A charge with Others amounted to Rs. 1.75 Cr with Charge ID 101282364 was registered on 10 Apr 2026.
Filing
Aptus Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Chetan Shantilal Lalseta ceased to be Director.
Appointed
Sejal Harit Palan was appointed as Director.
Appointed
Vikas Rambhai Jobanputra was appointed as Director.
Appointed
Jyotiben Hasmukhbhai Chandarana was appointed as Director.
Ceased
Chatrabhuj Vallabhbhai Butani ceased to be Director.
Ceased
Gaurang Rameshchandra Thakker ceased to be Director.

22 earlier events are in the company report.

Frequently asked questions

Aptus Pharma is an active public limited company based in Ahmedabad, Gujarat, India. The company works in wholesale, within the trading industry. It was incorporated on 12 August 2010 (16+ years old) and is registered under CIN U24230GJ2010PLC061957. Listed on BSE: 544529.

Aptus Pharma reported revenue of ₹46.57 Cr for FY 2025-26 (up 89.6% YoY) based on standalone financials.

Aptus Pharma has 6 current directors:

The latest financial statements of Aptus Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 September 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Aptus Pharma is 24AAICA7890D1ZM, registered in Gujarat.

The CIN (Corporate Identification Number) of Aptus Pharma is U24230GJ2010PLC061957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Aptus Pharma is a listed company as per MCA records. Its shares are listed on BSE (code: 544529).

Aptus Pharma has 2 court cases on record: 2 filed by the company.

Aptus Pharma was incorporated on 12 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Aptus Pharma has 11 deals on record (10 market trades, 1 ipo); the latest was in December 2025.

The peers of Aptus Pharma by revenue are Us Amino Private Limited, Zenacts Pharma Private Limited, Pvpharma Healthcare Private Limited, Saviour Wellness Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).